Natco Pharma Ltd. — Major Shareholding Notification 2019

Apr 15, 2019

Natco Pharma Limited

Regd. Off.: 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad - 500034. Telangana, INDIA. Tel: +91 40 23547532, Fax: +91 40 23548243 CIN: L24230TG1981PLC003201, www.natcopharma.co.in

April 4, 2019

Corporate Relationship Department M/s. BSE Ltd Dalal Street, Fort Mumbai 400 001

The Manager - Listing M/s. National Stock Exchange of India Ltd "Exchange Plaza", Bandra - Kurla Complex Bandra (E) Mumbai 400 051

Scrip Code: 524816

Scrip Code: NATCOPHARM

Dear Sir

Sub:- Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Please find enclosed herewith the Disclosures received from Sri V C Nannapaneni, under regulation (s) 30(1) & 30(2) of SEBI (substantial Acquisition of Shares and Takeovers) Regulations, 2011 as on 31st March, 2019.

Thanking you

Yours faithfully For NATCO Pharma Limited

MANESqyano

M Adinarayana Company Secretary & Vice President (Legal & Corp Affairs)

Format for Disclosures under Regulation 30(1) & 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

1. Name of the Target Company (TC)	NATCO Pharma Limited
2. Name (s) of the Stock Exchange(s) where theshares of the TC are listed	National Stock Exchange & BSE Ltd
3. Particulars of the Shareholdera. Name of person whose total holding(including that in the form of shares,warrants, convertible securities and any otherinstrument that would entitle the holder toreceive shares in the target company) is morethat 25% of the shares or Voting rights of theTCORb. Name(s) of Promoter(s), member of thepromoter group and persons acting in concert(PAC) with him	promoter group	V C NANNAPANENI on behalf of himself, as aPromoter and persons Acting in Concert (*) and
4. Particulars of the holding of personsmentioned at (3) above	Number	% w.r.t. totalshare/votingcapitalwhereverapplicable	% w.r.t. totaldilutedshare/votingcapital ofthe $TC(*)$
5. As on March 31, 2019, holding ofa. Sharesb. voting Rights (other wise that by shares)c. Warrantsd. Convertible Securities.e. Any other instrument that would entitle theholder to receive shares in the TC.	89081845	49.71	49.71

(*) persons acting in concert and promoter group Details and their share holding is attached as Annexure

Place: Hyderabad Date: April 4, 2019

Signature of Authorized Signatory: (V C Nannapaneni on behalf of himself, And Persons Acting in Concert)

Annexure

Details of shareholding of Promoters and Promoter Group persons along with Persons Acting in concert as on March 31, 2019

Name of the Promoter / personsacting in concert persons	Number	% w.r.t.totalshare/votingcapitalwhereverapplicable	% w.r.t. totaldilutedshare/votingcapital ofthe $TC(*)$
V C Nannapaneni	35311270	19.31	19.31
V C Nannapaneni HUF	5440045	2.97	2.97
Durga Devi Nannapaneni	3539100	1.94	1.94
Rajeev Nannapaneni	1128000	0.62	0.62
Neelima Sita Nannapaneni	182960	0.10	0.10
Venkata Satya Swathi Kantamani	3260000	1.78	1.78
Time Cap Pharma Labs Ltd	17157220	9.38	9.38
Natsoft Information Systems Pvt Ltd	15767500	8.62	8.62
Natco Aqua Limited	16000	0.01	0.01
Ndl Infra Tech Pvt Ltd	93750	0.05	0.05
N Ramakrishna Rao	747110	0.41	0.41
T Ananda Babu	473205	0.26	0.26
T Vidyadhari	442200	0.24	0.24
T Jhansi	77100	0.04	0.04
T Anila	629920	0.34	0.34
Vistra ITCL India LimitedA/c Neelima Nannapaneni Trust	4082750	2.23	2.23
VISTRA ITCL (INDIA) LIMITEDA/c Durga Devi Nannapaneni Trust	600000	0.33	0.33
Kantamani Ratna Kumar	100000	0.05	0.05
TBapineedu	415	0.00	0.00
Devendrnath Alapati	15000	0.01	0.01
Bapanna Alapati	18300	0.01	0.01

Place: Hyderabad Date: April 4, 2019

Signature of Authorized Signatory: (V C Nannapaneni on behalf of himself, And Persons Acting in Concert)